Treatment of Urinary Retention with the Axonics SNM system / Version 1

  • Research type

    Research Study

  • Full title

    Treatment of Urinary Retention using the Axonics Sacral Neuromodulation System INVESTIGATOR SPONSORED CLINICAL CASE SERIES

  • IRAS ID

    238135

  • Contact name

    Mahreen Pakzad

  • Contact email

    Mahreen.pakzad@nhs.net

  • Sponsor organisation

    University College London

  • Duration of Study in the UK

    1 years, 6 months, 30 days

  • Research summary

    Urinary retention (UR) is a problem that causes an inability to empty the bladder partially or completely. Sacral neuromodulation (SNM) is a well-established clinically proven therapy that uses electrical pulses to change bladder nerve activity to treat patients with bladder dysfunction such as Urinary retention, and overactive bladder. Axonics® has developed a new system that includes a rechargeable implantable device and easy to use components to improve patient experiences.
    This study is being conducted to learn more about how well the Axonics SNM System performs in people who have UR.
    Up to 20 patients will be recruited in this study and approximately 14 patients will be enrolled and will participate in this feasibility study at UCLH in London. All patients enrolled in the study will receive the same treatment.
    Participants will be in the study for about one year and will require at least 9 visits to the study center.

  • REC name

    London - Queen Square Research Ethics Committee

  • REC reference

    18/LO/1353

  • Date of REC Opinion

    8 Jan 2019

  • REC opinion

    Further Information Favourable Opinion